Patents Assigned to RACE ONCOLOGY LTD.
  • Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 11147800
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: October 19, 2021
    Assignee: Race Oncology Ltd.
    Inventors: William J. Garner, Arnie Franklin, John Rothman
  • Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 11135201
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof. Such methods and compositions are particularly useful for treatment of malignancies.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: October 5, 2021
    Assignee: RACE ONCOLOGY LTD.
    Inventors: William J. Garner, Amie Franklin, John Rothman
  • Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 10548876
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: February 4, 2020
    Assignee: RACE ONCOLOGY LTD.
    Inventors: William J. Garner, Amie Franklin, John Rothman
  • Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 10500192
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: December 10, 2019
    Assignee: RACE ONCOLOGY LTD.
    Inventors: William J. Garner, Amie Franklin, John Rothman
  • Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 9993460
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: June 12, 2018
    Assignee: RACE ONCOLOGY LTD.
    Inventors: William J. Garner, Amie Franklin, John Rothman
  • Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
    Patent number: 9974774
    Abstract: The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: May 22, 2018
    Assignee: RACE ONCOLOGY LTD.
    Inventors: William J. Garner, Amie Franklin, John Rothman